Skip to main content
Equibles

Ensign Peak Advisors, Inc

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1454984 SALT LAKE CITY, UT
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,710,413
+$9,569,609 QoQ
Shares Held
290,818
+4227.0% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#60
of 311 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. RARE ranks #33 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,483 $104,553,220
2 INSM
INSMED Inc
 702,951 $74,948,635
3 ABVX
Abivax S.A.
 504,471 $67,225,805
4 BBIO
BridgeBio Pharma, Inc.
 760,977 $56,677,566
5 ARGX
Argenx SE
 52,027 $48,269,089
6 PTCT
Ptc Therapeutics, Inc.
 508,056 $41,442,127
7 TVTX
Travere Therapeutics, Inc.
 591,815 $33,621,010
8 SRRK
Scholar Rock Holding Corp
 579,052 $31,847,860

All Filings in RARE

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,710,413 290,818
2026-03-31 $140,804 6,721
2025-12-31 $5,763,133 250,571
2025-09-30 $5,336,823 177,421
2025-06-30 $1,311,541 36,071
2025-03-31 $1,306,130 36,071
2024-12-31 $1,229,327 29,221
2024-09-30 $1,617,671 29,121
2024-06-30 $1,196,873 29,121
2024-03-31 $1,359,659 29,121
2023-12-31 $1,462,813 30,590
2023-09-30 $1,090,533 30,590
2023-06-30 $1,411,116 30,590
2023-03-31 $1,208,614 30,140
2022-12-31 $1,396,386 30,140
2022-09-30 $4,720,284 113,989
2022-06-30 $5,089,833 85,314
2022-03-31 $1,067,514 14,700
2021-12-31 $1,236,123 14,700